167 related articles for article (PubMed ID: 28965028)
21. Correlation between miR-103 and miR-133a Expression and the Circulating ANGPTL8 in Type 2 Diabetic Patients and Healthy Control Subjects.
Ghasemi H; Karimi J; Khodadadi I; Tavilani H
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710446
[TBL] [Abstract][Full Text] [Related]
22. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
Jeanes YM; Reeves S
Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
[TBL] [Abstract][Full Text] [Related]
23. Increased plasma and adipose tissue levels of ANGPTL8/Betatrophin and ANGPTL4 in people with hypertension.
Abu-Farha M; Cherian P; Qaddoumi MG; AlKhairi I; Sriraman D; Alanbaei M; Abubaker J
Lipids Health Dis; 2018 Mar; 17(1):35. PubMed ID: 29490644
[TBL] [Abstract][Full Text] [Related]
24. Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys.
Ayonrinde OT; Adams LA; Doherty DA; Mori TA; Beilin LJ; Oddy WH; Hickey M; Sloboda DM; Olynyk JK; Hart R
J Gastroenterol Hepatol; 2016 May; 31(5):980-7. PubMed ID: 26589977
[TBL] [Abstract][Full Text] [Related]
25. Circulating angiopoietin-like protein 8 (betatrophin) association with HsCRP and metabolic syndrome.
Abu-Farha M; Abubaker J; Al-Khairi I; Cherian P; Noronha F; Kavalakatt S; Khadir A; Behbehani K; Alarouj M; Bennakhi A; Elkum N
Cardiovasc Diabetol; 2016 Feb; 15():25. PubMed ID: 26850725
[TBL] [Abstract][Full Text] [Related]
26. Lack of associations between betatrophin/ANGPTL8 level and C-peptide in type 2 diabetic subjects.
Abu-Farha M; Abubaker J; Noronha F; Al-Khairi I; Cherian P; Alarouj M; Bennakhi A; Elkum N
Cardiovasc Diabetol; 2015 Aug; 14():112. PubMed ID: 26289721
[TBL] [Abstract][Full Text] [Related]
27. The Effects of Serum ANGPTL8/betatrophin on the Risk of Developing the Metabolic Syndrome - A Prospective Study.
Wang H; Lai Y; Han C; Liu A; Fan C; Wang H; Zhang H; Ding S; Teng W; Shan Z
Sci Rep; 2016 Jun; 6():28431. PubMed ID: 27345212
[TBL] [Abstract][Full Text] [Related]
28. The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity.
Luo M; Zhang Z; Peng Y; Wang S; Peng D
Cardiovasc Diabetol; 2018 Nov; 17(1):142. PubMed ID: 30409151
[TBL] [Abstract][Full Text] [Related]
29. Angiopoietin-like protein 8 (ANGPTL8)/betatrophin overexpression does not increase beta cell proliferation in mice.
Cox AR; Lam CJ; Bonnyman CW; Chavez J; Rios JS; Kushner JA
Diabetologia; 2015 Jul; 58(7):1523-31. PubMed ID: 25917759
[TBL] [Abstract][Full Text] [Related]
30. ANGPTL8 enhances insulin sensitivity by directly activating insulin-mediated AKT phosphorylation.
Zhang Z; Wu H; Dai L; Yuan Y; Zhu Y; Ma Z; Ruan X; Guo X
Gene; 2020 Jul; 749():144707. PubMed ID: 32344005
[TBL] [Abstract][Full Text] [Related]
31. Predictive values of ANGPTL8 on risk of all-cause mortality in diabetic patients: results from the REACTION Study.
Zou H; Xu Y; Chen X; Yin P; Li D; Li W; Xie J; Shao S; Liu L; Yu X
Cardiovasc Diabetol; 2020 Aug; 19(1):121. PubMed ID: 32746907
[TBL] [Abstract][Full Text] [Related]
32. Increased angiopoietin-like protein 8 levels in patients with type 2 diabetes and cardiovascular disease.
Huang Y; Fang C; Guo H; Hu J
Diabetes Res Clin Pract; 2016 Oct; 120():229-31. PubMed ID: 27596060
[TBL] [Abstract][Full Text] [Related]
33. Deciphering the expression dynamics of ANGPTL8 associated regulatory network in insulin resistance using formal modelling approaches.
Siddiqa A; Ahmad J; Ali A; Khan S
IET Syst Biol; 2020 Apr; 14(2):47-58. PubMed ID: 32196463
[TBL] [Abstract][Full Text] [Related]
34. Altered Concentrations in Dyslipidemia Evidence a Role for ANGPTL8/Betatrophin in Lipid Metabolism in Humans.
Gómez-Ambrosi J; Pascual-Corrales E; Catalán V; Rodríguez A; Ramírez B; Romero S; Vila N; Ibáñez P; Margall MA; Silva C; Gil MJ; Salvador J; Frühbeck G
J Clin Endocrinol Metab; 2016 Oct; 101(10):3803-3811. PubMed ID: 27472196
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the Expression and Prognostic Potential of a Novel Metabolic Regulator ANGPTL8/Betatrophin in Human Cancers.
Xu F; Tian D; Shi X; Sun K; Chen Y
Pathol Oncol Res; 2021; 27():1609914. PubMed ID: 34646087
[TBL] [Abstract][Full Text] [Related]
36. ANGPTL8 (Betatrophin) is Expressed in Visceral Adipose Tissue and Relates to Human Hepatic Steatosis in Two Independent Clinical Collectives.
von Loeffelholz C; Pfeiffer AFH; Lock JF; Lieske S; Döcke S; Murahovschi V; Kriebel J; de Las Heras Gala T; Grallert H; Rudovich N; Stockmann M; Spranger J; Jahreis G; Bornstein SR; Lau G; Xu A; Schulz-Menger J; Exner L; Haufe S; Jordan J; Engeli S; Birkenfeld AL
Horm Metab Res; 2017 May; 49(5):343-349. PubMed ID: 28351093
[TBL] [Abstract][Full Text] [Related]
37. High frequency of type 2 diabetes and impaired glucose tolerance in Japanese subjects with the angiopoietin-like protein 8 R59W variant.
Liu J; Yagi K; Nohara A; Chujo D; Ohbatake A; Fujimoto A; Miyamoto Y; Kobayashi J; Yamagishi M
J Clin Lipidol; 2018; 12(2):331-337. PubMed ID: 29397342
[TBL] [Abstract][Full Text] [Related]
38. Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD?
Gastaldelli A
Clin Sci (Lond); 2017 Nov; 131(22):2701-2704. PubMed ID: 29109303
[TBL] [Abstract][Full Text] [Related]
39. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
Asrih M; Jornayvaz FR
Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
[TBL] [Abstract][Full Text] [Related]
40. Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?
Targher G; Rossini M; Lonardo A
Endocrine; 2016 Feb; 51(2):211-21. PubMed ID: 26024975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
